Back to
State Street Corp.
RNAC
Showing 8 of 9 quarters
Position history for
State Street Corp.'s holdings in Cartesian Therapeutics, Inc.
Yes. State Street holds 249,212 shares of RNAC (Cartesian Therapeutics), worth $2.6M, as of its Q2 2026 13F filing. It increased the position by 48,875 shares (+24.4%) from Q1 2026. State Street has held RNAC in every 13F on record since Q2 2024, 9 quarterly filings.
Current Value
$2.6M
Current Shares
249,212
Total Value Change
+$57,970
Total Shares Change
+91,717
Quarter-by-Quarter History
Other major holders of RNAC: FMR LLC, Squarepoint Ops LLC